Clinical Trials Logo

Colonoscopy Preparation clinical trials

View clinical trials related to Colonoscopy Preparation.

Filter by:

NCT ID: NCT01610856 Completed - Clinical trials for Colonoscopy Preparation

Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy

Start date: March 2010
Phase: N/A
Study type: Interventional

Proper bowel cleansing prior is an essential requirement for the conduct of colonoscopy. However, due to the nature of cleansing process, the ideal bowel cleansing preparation remains elusive. The objective of this study is to compare the efficacy, safety and tolerability of oral polyethylene glycol lavage given either as a single dose or split dose. The study will be a randomized controlled single blind two group study. The primary study outcomes will be the previously validated Ottawa bowel preparation score.

NCT ID: NCT01596686 Completed - Clinical trials for Colonoscopy Preparation

Comparison of Preparation Regimens for Colonoscopy

Start date: May 2012
Phase: N/A
Study type: Interventional

The investigators intend to study the impact of two different preparation regimens for colonoscopy (PEG vs sodium picosulphate) on the quality of the endoscopy as well as patient tolerability.

NCT ID: NCT01531140 Completed - Clinical trials for Colonoscopy Preparation

PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy

Start date: November 2010
Phase: Phase 4
Study type: Interventional

Background: Polyethylene glycol (PEG) solution has been proven to be effective for large bowel cleansing prior to colonoscopy in children. However, the high volume of fluid and its taste sometimes lead to inappropriate cleansing of the bowel, thus search for other bowel preparation is needed. Aim: The efficacy and tolerability of three different bowel cleansing protocols used in children for colonoscopy: high-volume PEG compared with low-volume PEG with stimulant laxative (bisacodyl) compared with sennosides. Methods: Participants aged 10-18 years will be randomly assigned to receive either PEG 60 ml/kg/day or PEG 30 ml/kg/day plus oral bisacodyl 10-15 mg/day or sennosides 2mg/kg/day for 2 days prior to the colonoscopy. The outcome measures will be:bowel cleansing efficacy, scored by a blinded endoscopist using the Ottawa scale and Aronchick Scale (the mean total score, proportions of participants with excellent/good and with poor/inadequate bowel preparation), and the patient satisfaction score(0-10)with the method of preparation for the colonoscopy evaluated with the visual analog scale. Analysis will be done on an intention to treat basis.